Indivior Pharmaceuticals reported revenue of $343.00M and net income of $122.00M for the quarter ended Jun 2026, up 13.6% year over year. This income statement covers 13 quarters of results from Dec 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Dec2021 | Dec2022 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | |||||||||||||
| Revenue | 284.00M | 299.00M | 307.00M | 299.00M | 266.00M | 302.00M | 314.00M | 358.00M | 317.00M | 343.00M | |||
| Cost of RevenueCost of Rev | 38.00M | 79.00M | 66.00M | 48.00M | 44.00M | 52.00M | 83.00M | 67.00M | 40.00M | 50.00M | |||
| Gross Profit | 246.00M | 220.00M | 241.00M | 250.00M | 221.00M | 250.00M | 230.00M | 292.00M | 277.00M | 294.00M | |||
| Operating items | |||||||||||||
| Research & DevelopmentR&D | 28.00M | 26.00M | 22.00M | 31.00M | 22.00M | 21.00M | 33.00M | 21.00M | 16.00M | 12.00M | |||
| Selling, General & AdministrativeSG&A | 143.00M | 152.00M | 142.00M | 175.00M | 133.00M | 158.00M | 155.00M | 189.00M | 124.00M | 122.00M | |||
| Restructuring CostsRestructuring | 4.00M | -1.00M | -2.00M | ||||||||||
| Other Operating ExpensesOther Opex | -160.00M | -36.00M | 1.00M | -1.00M | -2.00M | -1.00M | |||||||
| Operating ExpensesOpex | 171.00M | 338.00M | 206.00M | 205.00M | 156.00M | 179.00M | 187.00M | 211.00M | 139.00M | 134.00M | |||
| Operating IncomeOp. Inc | 75.00M | -118.00M | 35.00M | 46.00M | 66.00M | 72.00M | 43.00M | 81.00M | 137.00M | 160.00M | |||
| EBIT | 75.00M | -118.00M | 35.00M | 46.00M | 66.00M | 72.00M | 43.00M | 81.00M | 137.00M | 160.00M | |||
| Non-operating items | |||||||||||||
| Non Operating Interest Expenses | 9.00M | 9.00M | 11.00M | 13.00M | 12.00M | 15.00M | 12.00M | 6.00M | 7.00M | 2.00M | |||
| Interest & Investment IncomeInt & Inv Inc | 7.00M | 6.00M | 5.00M | 5.00M | 4.00M | 6.00M | 6.00M | 6.00M | 3.00M | 3.00M | |||
| Other Non Operating IncomeOther Non Op Inc. | -18.00M | ||||||||||||
| Net income details | |||||||||||||
| EBT | 73.00M | -121.00M | 30.00M | 38.00M | 59.00M | 62.00M | 37.00M | 81.00M | 115.00M | 160.00M | |||
| Tax ProvisionsTaxes | 11.00M | -23.00M | 8.00M | 17.00M | 11.00M | 44.00M | -5.00M | -21.00M | 26.00M | 38.00M | |||
| Profit After TaxPAT | 61.00M | -97.00M | 22.00M | 21.00M | 47.00M | 18.00M | 42.00M | 102.00M | 89.00M | 122.00M | |||
| Income from Continuing OperationsIncome (Continuing) | 62.00M | -98.00M | 22.00M | 21.00M | 48.00M | 18.00M | 42.00M | 102.00M | 89.00M | 122.00M | |||
| Consolidated Net IncomeConsol Net Inc. | 62.00M | -98.00M | 22.00M | 21.00M | 48.00M | 18.00M | 42.00M | 102.00M | 89.00M | 122.00M | |||
| Income towards Parent CompanyParent Net Inc | 62.00M | -98.00M | 22.00M | 21.00M | 48.00M | 18.00M | 42.00M | 102.00M | 89.00M | 122.00M | |||
| Net Income towards Common StockholdersNet Income | 62.00M | -98.00M | 22.00M | 21.00M | 48.00M | 18.00M | 42.00M | 102.00M | 89.00M | 122.00M | |||
| Additional items | |||||||||||||
| EPS (Basic) | 0.46 | -0.73 | 0.17 | 0.16 | 0.39 | 0.14 | 0.34 | 0.82 | 0.72 | 1.03 | |||
| EPS (Diluted) | 0.45 | -0.73 | 0.17 | 0.16 | 0.38 | 0.14 | 0.33 | 0.80 | 0.69 | 0.98 | |||
| Shares Outstanding | 145.66M | 139.00M | 137.00M | 136.00M | 135.00M | 132.00M | 132.00M | 124.00M | 125.00M | 125.00M | 125.00M | 124.00M | 119.00M |
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 151.94M | 139.00M | 137.00M | 137.00M | 135.00M | 133.00M | 133.00M | 125.00M | 126.00M | 129.00M | 128.00M | 129.00M | 124.00M |
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 145.66M | 136.48M | 136.53M | 136.00M | 135.00M | 132.00M | 124.66M | 124.77M | 124.77M | 124.85M | 125.07M | 121.92M | 118.01M |
| EBITDA | 75.00M | -118.00M | 35.00M | 46.00M | 66.00M | 72.00M | 43.00M | 81.00M | 137.00M | 160.00M | |||
| Interest ExpensesInt Expense | 9.00M | 9.00M | 11.00M | 13.00M | 12.00M | 15.00M | 12.00M | 6.00M | 7.00M | 2.00M | |||
| Tax Rate | 15.07% | 19.01% | 26.67% | 44.74% | 18.64% | 70.97% | -13.51% | -25.93% | 22.61% | 23.75% |